Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new ...
Patients who have been treated for heart failure and experience an improvement in their pump function are still at higher ...
11don MSN
Emmanuel Valentin, 40, of Miami, pleaded guilty to tampering with consumer products on Dec. 13, 2024, according to a press ...
The FDA approval was based on results from the CABINET study, a phase 3 pivotal trial evaluating cabozantinib compared with ...
GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions ...
Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results